%0 Journal Article
%T Clinical Comparison of Drug-Coated Balloon and Drug-Eluting Stent for Femoropopliteal Lesions in Chronic Limb-Threatening Ischemia With Wounds.
%A Ogata K
%A Nishihira K
%A Asano Y
%A Honda Y
%A Yamamoto K
%A Emori H
%A Kadooka K
%A Kimura T
%A Kudo T
%A Ashikaga K
%A Shibata Y
%A Tsujita K
%J Circ J
%V 0
%N 0
%D 2024 Jul 26
%M 39069494
%F 3.35
%R 10.1253/circj.CJ-24-0176
%X <B>BACKGROUND: </B>Endovascular therapy (EVT) with devices such as drug-coated balloons (DCBs) and drug-eluting stents (DESs) for atherosclerotic disease in the femoropopliteal (FP) artery has been established. However, EVT using drug-based devices for chronic limb-threatening ischemia (CLTI) remains challenging. The optimal device for FP lesions in patients with CLTI remains unknown. This study compared the clinical efficacy of DCB and DES in patients with CLTI and FP lesions.Methods and Results: This retrospective single-center study included 539 consecutive patients (562 lesions) treated with EVT between January 2018 and December 2022; 166 patients with CLTI and Rutherford Class 5 or 6 wounds underwent EVT with DCB or DES. Clinical outcomes were compared between 53 pairs after propensity score matching. There were no significant differences between the DCB and DES groups in the incidence of complete wound healing without death or major amputation (84.8% vs. 80.2%, respectively; P=0.99), primary patency (69.4% vs. 75.6%, respectively; P=0.65), and freedom from target lesion revascularization at 1 year (78.6% vs. 78.0%, respectively; P=0.92). Multivariate analysis showed that complete wound healing at 1 year is negatively associated with hemodialysis and Wound, Ischemia, and foot Infection Stage 4, but positively associated with Global Limb Anatomic Staging System FP Grade 3 or 4.<BR><B>CONCLUSIONS: </B>No significant differences in clinical outcomes were found between DCB and DES for patients with CLTI and FP lesions.